Acquired Bleeding Disorder Completed Phase 3 Trials for Coagulation factor VIIa Recombinant Human (DB00036)

IndicationStatusPhase
DBCOND0030736 (Acquired Bleeding Disorder)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00127283Recombinant Factor VIIa in Acute Intracerebral HaemorrhageTreatment